There’s a new plot twist in the takeover battle between French pharmaceutical giant Sanofi-Aventis and U.S. drugmaker Genzyme. A regulatory filing made by Genzyme on Thursday claims Sanofi may be willing to go much higher than …
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Continue reading J&J to Ac…
In testimony before Congress Thursday, Johnson & Johnson’s CEO apologized for the problems that have beset his company, including the quality issues with its children’s medicines and the “phantom recall” of a batch of Motrin. …
You know better than to believe everything companies say in ads, but when it comes to claims about the healthfulness of foods and other products, the untruths can reach outrageous levels. The question is: What can a government …